文献
J-GLOBAL ID:201202251404970275
整理番号:12A1077752
PIM-1、PIM-2およびPIM-3タンパク質キナーゼの強力かつ選択的阻害剤としての新規ベンジリデン-1,3-チアゾリジン-2,4-ジオンの発見
Discovery of novel benzylidene-1,3-thiazolidine-2,4-diones as potent and selective inhibitors of the PIM-1, PIM-2, and PIM-3 protein kinases
著者 (18件):
DAKIN Les A.
(Oncology iMed Sciences Group, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, USA)
,
BLOCK Michael H.
(Oncology iMed Sciences Group, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, USA)
,
CHEN Huawei
(Oncology iMed Sciences Group, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, USA)
,
CODE Erin
(Oncology iMed Sciences Group, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, USA)
,
DOWLING James E.
(Oncology iMed Sciences Group, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, USA)
,
FENG Xiaomei
(Oncology iMed Sciences Group, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, USA)
,
FERGUSON Andrew D.
(Discovery Sciences - Structure and Biophysics, AstraZeneca, 35 Gatehouse Drive, Waltham, MA 02451, USA)
,
GREEN Isabelle
(Discovery Sciences - Reagents and Assay Dev., AstraZeneca, Alderley Park, Cheshire SK10 4TG, GBR)
,
HIRD Alexander W.
(Oncology iMed Sciences Group, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, USA)
,
HOWARD Tina
(Discovery Sciences - Structure and Biophysics, AstraZeneca, Alderley Park, Cheshire SK10 4TG, GBR)
,
KEETON Erika K.
(Oncology iMed Sciences Group, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, USA)
,
LAMB Michelle L.
(Oncology iMed Sciences Group, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, USA)
,
LYNE Paul D.
(Oncology iMed Sciences Group, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, USA)
,
POLLARD Hannah
(Discovery Sciences - Reagents and Assay Dev., AstraZeneca, Alderley Park, Cheshire SK10 4TG, GBR)
,
READ Jon
(Discovery Sciences - Structure and Biophysics, AstraZeneca, Alderley Park, Cheshire SK10 4TG, GBR)
,
WU Allan J.
(Oncology iMed Sciences Group, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, USA)
,
ZHANG Tao
(Oncology iMed Sciences Group, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, USA)
,
ZHENG Xiaolan
(Oncology iMed Sciences Group, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, USA)
資料名:
Bioorganic & Medicinal Chemistry Letters
(Bioorganic & Medicinal Chemistry Letters)
巻:
22
号:
14
ページ:
4599-4604
発行年:
2012年07月15日
JST資料番号:
W0248A
ISSN:
0960-894X
資料種別:
逐次刊行物 (A)
発行国:
オランダ (NLD)
言語:
英語 (EN)